Active	Status	Sponsor type	Region	Phase	Filter
2 Active 4 Inactive 6 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Sen, Sabyasachi
NCT04126603: Impact of Semaglutide on CD34+ EPC and Fat Derived MSC	Completed	4	38	US	Semaglutide, Placebos	Sabyasachi Sen	Diabetes Mellitus, Type 2	10/23	10/23
NDKD, NCT06110130: Effect of Empagliflozin on Podocyte Specific Proteins in African American Veterans With	Recruiting	4	60	US	Empagliflozin 10 MG, Placebo	Washington D.C. Veterans Affairs Medical Center, Boehringer Ingelheim	Chronic Kidney Diseases	12/25	12/26